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Abstract
Background: It is quite common that the genetic architecture of complex traits involves many
genes and their interactions. Therefore, dealing with multiple unlinked genomic regions
simultaneously is desirable.
Results: In this paper we develop a regression-based approach to assess the interactions of
haplotypes that belong to different unlinked regions, and we use score statistics to test the null
hypothesis of non-genetic association. Additionally, multiple marker combinations at each unlinked
region are considered. The multiple tests are settled via the minP approach. The P value of the
"best" multi-region multi-marker configuration is corrected via Monte-Carlo simulations. Through
simulation studies, we assess the performance of the proposed approach and demonstrate its
validity and power in testing for haplotype interaction association.
Conclusion: Our simulations showed that, for binary trait without covariates, our proposed
methods prove to be equal and even more powerful than htr and hapcc which are part of the
FAMHAP program. Additionally, our model can be applied to a wider variety of traits and allow
adjustment for other covariates. To test the validity, our methods are applied to analyze the
association between four unlinked candidate genes and pig meat quality.
Background
Haplotypes, the linear arrangement of alleles on the same
chromosome inherited as a unit, provide a natural frame-
work for testing the association between genetic markers
and complex traits more efficiently than separate marker
analysis[1]. There is strong evidence that several muta-
tions in cis position within a single gene can interact to
create a "super allele" that has a large effect on the
observed phenotype. The biological explanation for these
haplotype effects is that several mutations in a gene cause
several amino acid changes in the ultimate protein prod-
uct, and the joint effect of these amino acid changes can
have a much larger influence on the function of the pro-
tein product than any single amino acid change. This
emphasizes the importance of examining candidate genes
by SNP haplotyping. Some studies focus on haplotypes
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within a given genomic region [2-7]. Because complex
traits are presumed to be the results of interaction by a set
of genes which may be located in different regions, some
methods aim to test gene-gene interaction, and interac-
tions of single markers from different unlinked regions [8-
11]. Specifically, Becker et al[12] reported a method to
deal with haplotype interaction in unlinked regions for a
binomial trait. They find the best haplotype combination
from the unlinked regions by permutation, which is a
modification of Ge et al[13]. However, this method could
only be applied to case-control association testing, and
could not include other covariates.
Generalized Linear Model (GLM) is an extension of the
general linear modeling process that allows models to be
fitted for several kinds of traits, such as Gaussian, Poisson,
Binomial, etc., and allows various covariates. Schaid et
al[5] introduced score statistics, which are receiving
increased attention because they require only computa-
tion of the null estimates and are asymptotically equiva-
lent to Wald and likelihood ratio statistics under both null
and Pitman alternative hypotheses. Some methods that
use score tests based on GLM to test haplotype-trait asso-
ciation have demonstrated the validity and power of this
statistic[6]. However, these methods only considered one
genomic region. If considering multi-region multi-marker
haplotype configurations, a severe multiple-testing prob-
lem will occur. To obtain uncorrected P-values for a spe-
cific marker combination, we use an unnested simulation
introduced by Becker and Knapp[2], which is based on the
algorithm proposed by Ge et al[13].
We propose an alternative approach that uses score statis-
tics based on GLM to build the statistic T over which some
of the unlinked regions are considered and some markers
are chosen at the selected regions. Since the distribution of
T is generally unknown and is generally not comparable,
we replace T with Pmin which is inherited from the algo-
rithm of Becker and Knapp[2]. This simulation method
has already been validated by Manly[14] and Hoh et
al[15], and has systematically been applied to some
genetic data[2,12,16,17].
Simulation study
Simulation schemes
We conduct a simulation study to evaluate the power and
type I error of the association test and to compare our
approach with others. The haplotype data are generated in
a way similar to that of Roeder et al.[18] and Tzeng et al[6].
In every simulation scheme, we consider two unlinked
regions. We consider that markers are in strong linkage
disequilibrium within each region, but markers from dif-
ferent regions are in linkage equilibrium. Therefore, we
separately produce two regions by using a modified Hud-
son's MS program[19]. This program generates data under
a coalescent model in which the recombination occurs
uniformly over the region. The 4 samples sizes are 50,
100, 200 and 400, respectively. The scaled recombination
rate, ρ = Neδ/bp, is set to 4 × 10-3 for the recombination
cold spots, and 100 times greater in the hot spots, with the
effective population size Ne is 1 × 104. The scaled muta-
tion for the entire region, 4Neμ/bp, is set to be 6 × 10-4.
Once the haplotypes have been generated, the first step is
to restrict the disease or minor allele frequency. In this
simulation, we set the allele frequency as 3 levels: 0.1, 0.3,
and 0.5. We assume that the middle locus in every gene is
the liability locus. Once a liability locus is chosen, a hap-
lotype is defined as a segment of three adjacent SNPs in
which the second SNP is the liability locus.
After randomly pairing haplotypes to form individual
genotypes, we generate both continuous and binary trait
values.
Continuous traits
For the Type I error test, we consider two simple models of
quantitative traits simulated independently of the liability
locus. Let model 1 include only an environmental effect e: Y
= e. Let model 2 additionally incorporate a covariate Z: Y = γ
× Z + e. In the models, e follows a standard normal distribu-
tion with mean 0 and variance 1, and Z is generated from a
standard normal distribution. For assessing power and the
effective selection of the best combination of markers, we
also consider two models of quantitative traits simulated in
association with the liability locus. Let model 3 decompose
the trait value into MRHC effect and environmental effect e:
Y = g + e, and model 4 additionally incorporate a covariate Z:
Y = g + γ × Z + e. In these models, g is the sum of all consid-
ered genes' effects. For the ith gene, gi has a discrete distribu-
tion and equals  ,  ,   with probabilities q2, 2q(1-q)
and (1-q)2, respectively. As in models 1 and 2, e follows a
normal distribution with mean ε and variance  , and Z is
generated from a standard normal distribution. For simplic-
ity, we set  , ε = 0, and γ = 1. The trait values are
generated using the normal penetrance function.
 for the first model
and   for
the second model, where m is the number of the genes. We
determine   through the heritability h2 of all liability loci,
which we set at 0.4.
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Binary traits
We generate binomial phenotypes on the basis of the
above continuous traits, and consider four models where
the disease prevalence is set to 0.10. If the values of the
above continuous traits are more than a given threshold,
we set the traits as disease cases, otherwise we set them as
control. Let model 5 be the binary trait created from a con-
tinuous trait simulated as in model 1, model 6 from
model 2, model 7 from model 3, and model 8 from
model 4. Binary traits are simulated until an equal
number of cases and controls are reached.
The detail of the models can be seen in table 1.
Under all scenarios, we compute the global P value with
1500 permutation replicates for each simulated data set.
Empirical significance levels and power were computed as
the portion of simulated data sets for which the global P
value was less than or equal to 0.05.
Results
Comparison of three models htr, hapcc and HAPGLM
In order to check the validity and the accuracy of our
HAPGLM approach, we first carry out simulations under
the null hypothesis and compare it with hapcc and htr,
which were implemented in the beta version of FAMHAP.
htr performs a haplotype trend regression test proposed
by Zaykin et al[7], and hapcc performs a χ2 test for haplo-
types proposed by Becker et al[12,16]. Here, we use model
5 and 7 to simulate the trait. Haplotypes and trait values
are compared according to the frequency (q = 0.1, 0.3,
0.5) of the disease allele, and sample size (n = 50, 100,
200, 400).
First, we discuss the results under the effect of minor allele
frequency for type I error in table 2. Under 12 scenarios,
the type I error of the three models is near 0.05, and there
are not significant differences between the three models.
The results show that our model can approximate to
hapcc and htr in accuracy. For the power comparison,
table 3 presents worst performance when disease allele
frequency is high with small sample sizes, where the
power of the global test is not stabilized, especially for the
hapcc. The reason is that the disease individual prevalence
is 0.10, and the percent for the disease is somewhat small,
making it difficult to find the significant difference. How-
ever, when the sample size is more than 100, the power is
near one for the three models. There are no significant dif-
ferences among hapcc, htr and our method.
Three factors analysis for global test
To evaluate the test performance, we describe the results
from our power and type I error study that use the above
methods with various parameters. Type I error test
includes 48 scenarios which include 4 models, 3 minor
allele frequencies and 4 sample sizes. As shown in table 4,
the type I error stabilizes in all the scenarios. Power test
includes 48 scenarios which include 4 models, 3 disease
allele frequencies and 4 same sizes. For the power calcula-
tions in table 5, the power is adversely affected by the
small sample size and high disease allele frequency. Oth-
erwise, if the sample size is at least to 100, the power is
preserved. Therefore, we set sample size to test recombina-
tion affection and the specific MRHC testing as 100.
Recombination analysis for global test
In order to check the effect of recombination on the
model, we first consider two different recombination lev-
els at which the diversity of the haplotype is high and low.
"High diversity" indicates that a minor or disease locus is
located in the region of recombination hot spots and that
the number of distinct haplotypes is 6-8; "low diversity"
indicates that a minor or disease locus is located in a hap-
lotype block and the number of distinct haplotype is 3-5.
In this simulation, we consider three SNPs in each region
and we assume equal recombination level. The first
recombination level has 2-4 different haplotypes. The
haplotype distribution of the second recombination level
consists of 6-7 theoretically possible haplotypes. From
table 6 and 7, there are some differences between the two
diversities on type I error and power, but there are no sig-
nificant differences between the high and low diversities.
Table 1: the 8 models in the trait producing in simulation
Model name Trait type Factor consider
Model 1 Continuous traits include only an environmental effect e
Model 2 Continuous traits include an environmental effect e and a covariate
Model 3 Continuous traits include MRHC effect and environmental effect e
Model 4 Continuous traits include MRHC effect and environmental effect e and a covariate
Model 5 Binary Traits Produce from model 1 above a given threshold
Model 6 Binary Traits Produce from model 2 above a given threshold
Model 7 Binary Traits Produce from model 3 above a given threshold
Model 8 Binary Traits Produce from model 4 above a given thresholdBMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
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That is to say, the proposed method is not significantly
affected by the recombination level.
Analysis for specific MRHC
The score test can easily compute the specific MRHC. In
order to study the performance of the proposed method
in detecting individual MRHCs, we set 3 disease allele fre-
quencies and 4 model fits. The power for specific MRHC
is presented in table 8. It is of interest that the proposed
method is robust for detecting the specific MRHC.
Select the best combination of markers
In order to check the accuracy of our methods to select the
best MRHC, the markers of the 2 genes in simulations are
123|456, and the marker 2 and 5 are as the liability loci.
The frequency of the disease allele is 0.3. The result shows
that for these 2 liability loci combination, the statistic T is
the largest and the P value is the smallest. These are pre-
sented in table 9. The combination without these two loci
presents low T and high P value.
Application to a pig meat quality dataset
Meat quality is very important in the pig meat production
industry. Many candidate genes have been identified that
could be used to improve this trait through marker
assisted selection (MAS)[20]. The Heart Fatty Acid-Bind-
ing (H-FABP) gene encodes a type of cytosol protein that
transports fatty acids from the cell membrane to other
sites where 3-acyl-glyceride and phospholipids are synthe-
sized and fatty acids are oxidized. Gerbens [21-23] discov-
ered Msp I, Hae II and Hinf I polymorphisms of the H-
FABP gene that is related to intramuscular fat content.
Melanocortin-4 Receptor (MC4R) is believed to be a link
between feed intake and body weight[24].
Polymorphism of the MC4R gene has been reported to be
associated with back fat thickness[25]. Adipocyte Deter-
mination and Differentiation factor-1 (ADD1) can acti-
vate or restrain some genes in fat and glucose metabolism.
Research has suggested that the ADD1 gene can be used as
a candidate gene for pork quality[26]. Calpastatin (CAST),
which is an endogenous inhibitor (Ca2+  dependent
Table 2: Type I error of three models via 1500 simulations at α = 0.05
Sample Size Minor Allele Model Type
hapcc htr HAPGLM
50 q = 0.1 0.097(0.079-0.117) 0.048(0.036-0.063) 0.048(0.036-0.063)
q = 0.3 0.032(0.022-0.045) 0.039(0.028-0.053) 0.044(0.032-0.059)
q = 0.5 0.029(0.020-0.041) 0.041(0.030-0.055) 0.047(0.042-0.071)
100 q = 0.1 0.036(0.025-0.049) 0.035(0.024-0.048) 0.047(0.035-0.062)
q = 0.3 0.031(0.021-0.044) 0.072(0.057-0.090) 0.043(0.031-0.057)
q = 0.5 0.042(0.030-0.056) 0.047(0.035-0.062) 0.051(0.038-0.067)
200 q = 0.1 0.031(0.021-0.044) 0.026(0.017-0.038) 0.055(0.042-0.071)
q = 0.3 0.051(0.038-0.067) 0.033(0.023-0.046) 0.047(0.035-0.062)
q = 0.5 0.040(0.029-0.054) 0.067(0.052-0.084) 0.037(0.026-0.051)
400 q = 0.1 0.035(0.024-0.048) 0.037(0.026-0.051) 0.042(0.030-0.056)
q = 0.3 0.047(0.035-0.062) 0.028(0.019-0.040) 0.041(0.030-0.055)
q = 0.5 0.028(0.019-0.040) 0.041(0.030-0.055) 0.042(0.030-0.056)
Table 3: Power of three models via 1500 simulations at α = 0.05
Sample Size Disease Allele Frequency Model Type
hapcc htr HAPGLM
50 q = 0.1 0.947 0.947 0.947
q = 0.3 0.866 0.907 0.968
q = 0.5 0.666 0.391 0.596
100 q = 0.1 0.977 0.971 0.952
q = 0.3 0.963 0.927 0.941
q = 0.5 0.834 0.728 0.917
200 q = 0.1 0.980 0.980 0.968
q = 0.3 0.981 0.981 0.968
q = 0.5 0.961 0.912 0.954
400 q = 0.1 0.967 0.981 0.948
q = 0.3 0.981 0.983 0.974
q = 0.5 0.934 0.925 0.967BMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
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cysteine proteinase), plays a central role in the regulation
of calpain activity in cellsand is considered to be one of
the major modulators of the calpains[27,28]. The CAST
gene represents an excellent candidate gene for studying
variation in pork quality. We aim to find association
between multi-region haplotype effects from these candi-
date regions and meat quality.
Our data set is a sample which includes 93 unrelated fat-
teners from the following breeds/populations: 18 Meis-
han, 21 Sutai, 14 Yorkshire × Sutai, 16 Landrace × Sutai
and 24 Duroc × Landrace × Yorkshire pigs. 8 polymorphic
markers of the preceding genes in the populations have
been reported[29,30], which are: 2 in ADD1, 1 in H-FABP,
1 in MC4R and 4 in CAST. We code these polymorphic
markers as (A1, A2, H1, M1, C1, C2, C3, and C4). The χ2
test of these polymorphic markers show that there are sig-
nificant differences in 5 polymorphic markers (except for
A1, A2, C4) between the five populations. We set up single
locus models including sex and breed as environmental
covariates, for every polymorphic marker, and use statisti-
cal software SAS macro GLM for calculations. The results
show significant effects at 0.05 level for: A1, H1, C2, C3
and C4 in back fat thickness (BK); A1, C1 and C3 in meat
color (MC); A1, H1, C1 and C4 in intramuscular fat con-
tent (IMF), and A1 in protein content. To apply our meth-
ods, we also incorporate two environmental covariates
(sex and breed), and use back fat thickness, tenderness,
drip loss, meat color, intramuscular fat content, pH 1
hour after slaughter, pH 24 hours after slaughter, and the
content of protein as the dependent variable in the regres-
sion model. Table 10 illustrates the marker combination
in which raw P values are lower at 0.01 level, Compared
to single locus model, MRHC analysis can detect more
markers which are significantly associated with traits.
Additionally, our methods are used to reconstruct the dis-
tinct MRHC from the above 4 genes which are in unlinked
Table 4: Type I error of global test via 1500 simulations at α = 0.05
Sample Size Minor Allele Frequency Model Type
Model 1 Model 2 Model 5 Model 6
50 q = 0.1 0.034(0.024-0.047) 0.031(0.021-0.044) 0.048(0.036-0.063) 0.039(0.028-0.053)
q = 0.3 0.050(0.037-0.065) 0.041(0.030-0.055) 0.044(0.032-0.059) 0.044(0.032-0.059)
q = 0.5 0.052(0.039-0.068) 0.062(0.048-0.079) 0.047(0.035-0.062) 0.056(0.043-0.072)
100 q = 0.1 0.040(0.029-0.054) 0.032(0.022-0.045) 0.047(0.035-0.062) 0.037(0.026-0.051)
q = 0.3 0.038(0.027-0.052) 0.044(0.032-0.059) 0.043(0.031-0.059) 0.037(0.026-0.051)
q = 0.5 0.048(0.036-0.063) 0.044(0.032-0.059) 0.051(0.038-0.067) 0.052(0.039-0.068)
200 q = 0.1 0.045(0.033-0.060) 0.041(0.030-0.055) 0.055(0.042-0.071) 0.031(0.021-0.044)
q = 0.3 0.048(0.036-0.063) 0.041(0.030-0.055) 0.047(0.035-0.062) 0.042(0.030-0.056)
q = 0.5 0.047(0.035-0.062) 0.049(0.036-0.064) 0.037(0.026-0.051) 0.041(0.030-0.055)
400 q = 0.1 0.027(0.018-0.039) 0.040(0.029-0.054) 0.042(0.030-0.056) 0.038(0.027-0.052)
q = 0.3 0.043(0.031-0.059) 0.037(0.026-0.051) 0.041(0.030-0.055) 0.044(0.032-0.059)
q = 0.5 0.041(0.030-0.055) 0.052(0.039-0.068) 0.042(0.030-0.056) 0.048(0.036-0.063)
Table 5: Power of global test via 1500 simulations at α = 0.05
Sample Size Disease Allele Frequency Model Type
Model 3 Model 4 Model 7 Model 8
50 q = 0.1 0.977 0.824 0.947 0.478
q = 0.3 0.964 0.920 0.968 0.891
q = 0.5 0.947 0.625 0.596 0.741
100 q = 0.1 0.934 0.936 0.952 0.937
q = 0.3 0.979 0.957 0.941 0.889
q = 0.5 0.965 0.836 0.917 0.887
200 q = 0.1 0.978 0.963 0.968 0.916
q = 0.3 0.968 0.972 0.968 0.967
q = 0.5 0.967 0.971 0.954 0.960
400 q = 0.1 0.968 0.967 0.948 0.944
q = 0.3 0.971 0.947 0.974 0.920
q = 0.5 0.948 0.958 0.967 0.962BMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
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regions. In table 11, we illustrate the 5 top statistics for
MRHCs which consider 8 markers combination.
Discussion
Presently many publications have proven that the genetic
dissection of complex traits depends not only on the iden-
tification of genes involved in disease susceptibility but
also on the elucidation of the synergistic role that genes
play with other genes and with environmental factors[8-
11,31-33]. Therefore, considering unlinked genomic
regions simultaneously is desirable. There are two models
hapcc and htr in FAMHAP program which can compute
the haplotype interaction in unlinked region. For hapcc,
Becker et al.[12] chose the usual χ2 test statistic for contin-
gency tables which can be applied only to case-control
traits. For htr, the haplotype trend regression test pro-
posed by Zaykin et al[7], chose F statistic and could be
used for qualitative and quantitative traits, but won't
allow other covariates in the model. Our proposed meth-
ods are based on score equations for GLMs which allow
adjustment of covariates and can model qualitative and
quantitative traits. For binary trait without covariate, the
type I error and power comparison show that our model
has the same power as hapcc and htr, and type I error is as
expected. For a small number of markers, the run times for
hapcc, htr and HAPGLM are approximately equal. Addi-
tionally, our model has obvious advantages. First, our
model can be applied to analyze haplotype association
across independent regions with adjusting of covariates
for a wider variety of traits. Second, the score statistic ( )
of the individual MRHCs can be easily computed.
Our model adopted the simulation method proposed by
Becker et al.[2,12,17], which can be computationally fea-
sible to deal with the multiple marker combination. For
our program, the evaluation of a single simulated data set
with 15 markers in 3 regions will take no more than 10
seconds on average on two nodes with 3.0 GHz Intel with
512 MB main memory. In general, it will be possible to
simultaneously consider about 600 to 1,200 hypotheses
on a standard PC. Our program is very flexible to allow
selection of loci and genes for analysis. However, in
regions with too many possible haplotype combinations,
our program runs out of memory. We need to consider
more aggressive trimming parameters or other haplotype
estimation algorithms. For example, we will improve our
program by using the haplotype ancestral cluster idea to
cluster rare haplotypes with similar ancestral haplotypes,
which was used by Tzeng et al.[34]. Haplotypes of the
entire block can be represented by a smaller set of SNPs
which are referred to as tag SNPs[35]. In order to analyze
more markers, it will be helpful to select tag markers at
each region and to carry out the analysis on the set of these
markers. Tag SNPs selection will save run-time, and we
plan our further research along this path.
In this research, we proposed markers from different
regions which are proposed to be in linkage equilibrium.
zk
2
Table 6: Type I error of global test for different recombination at α = 0.05
Haplotype Diversity Minor Allele Frequency Model Type
Model 1 Model 2 Model 5 Model 6
High 0.1 0.046(0.034-0.061) 0.053(0.040-0.069) 0.045(0.033-0.060) 0.043(0.031-0.057)
0.3 0.051(0.038-0.067) 0.043(0.031-0.057) 0.047(0.035-0.062) 0.038(0.027-0.052)
0.5 0.058(0.044-0.074) 0.052(0.039-0.068) 0.042(0.030-0.056) 0.042(0.030-0.056)
Low 0.1 0.047(0.035-0.062) 0.041(0.030-0.055) 0.042(0.030-0.056) 0.043(0.031-0.057)
0.3 0.039(0.028-0.053) 0.044(0.032-0.059) 0.037(0.026-0.051) 0.047(0.035-0.062)
0.5 0.040(0.029-0.054) 0.051(0.038-0.057) 0.044(0.032-0.059) 0.050(0.037-0.065)
Table 7: Power of global for different recombination level at α = 0.05
Haplotype Diversity Disease Allele Frequency Model Type
Model 3 Model 4 Model 7 Model 8
high 0.1 0.971 0.860 0.955 0.957
0.3 0.967 0.962 0.961 0.961
0.5 0.948 0.968 0.953 0.965
low 0.1 0.973 0.977 0.972 0.972
0.3 0.963 0.944 0.951 0.958
0.5 0.977 0.933 0.948 0.953BMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
Page 7 of 11
(page number not for citation purposes)
Markers from different regions can be in linkage disequi-
librium, but the methods can allow such markers as if
they were in the same region.
Since the current model assumes that the subjects are
independent of each other (i.e., unrelated), it is critical to
extend the current approach to account for the correla-
tions between subjects, given their family data. Therefore,
further studies are needed to address the impact and mod-
eling strategies with regard to the assumptions in the
model. This model is restricted to outcomes that can be
placed in the generalized linear model framework. An
extension to failure-time data could also be placed in the
framework.
Conclusion
It is quite common that the genetic architecture of com-
plex traits involves many genes and their interactions.
Therefore, dealing with multiple unlinked genomic
regions simultaneously is desirable. We developed a
regression-based approach which can be applied to a
wider variety of traits and allow adjustment for other cov-
ariates to assess the interactions of haplotypes that belong
to different unlinked regions. Multiple marker combina-
tions at each unlinked region are also considered. In addi-
tion, HAPGLM can be downloaded for free at: ftp://
public.sjtu.edu.cn/, user: ylhu0323, password: public.
Methods
Contribution to multi-region haplotype configurations
Consider R unlinked genomic regions, and mr observed
markers for each of n unrelated individuals in region r.
Further, we suppose that markers within each region are
in strong linkage disequilibrium, while markers from dif-
ferent regions are in linkage equilibrium. What we wish to
investigate is whether some of the genomic regions are
associated with the phenotype of interest via some of the
markers from each region.
Let Gr be the multi-locus genotype of an individual at
region r, and hr be a haplotype of region r. If the haplo-
types   and   are compatible with Gr,   is  then
called a haplotype explanation of Gr. Obviously, for a
given Gr, there may be several haplotype explanations.
First, we use the expectation-maximization (EM) algo-
rithm[5] to obtain the maximum-likelihood estimates of
the haplotype frequencies at each of the unlinked regions.
After we pooled the rare haplotypes (with estimated fre-
quencies <0.001) into a single group, we adopt the fol-
lowing formula ([12] to compute the likelihood weights
of all haplotype explanations of each region for each indi-
vidual,
where Gr is the multilocus genotype of a fixed individual
at region r. Let   be the set of
unordered haplotype explanation, which are compatible
with Gr. let   be the estimated frequency of haplotype
, the sum in the denominator runs over all possible
haplotype explanations, and the Kronecker symbol δ is
defined as δj, k = 1 if j = k, and δj, k = 0 if j ≠ k, where j and
k is the pair of haplotypes at region r. The "~r" is all the
pair haplotypes in region r for each individual.
Let G = (G1, G2, and, GR) be the multi-region genotype of
an individual and   be a pos-
sible multi-region haplotype explanations (MRHEs) that
are compatible with (G1, G2, and, GR). Let 
denote a multi-region haplotype configuration (MRHC).
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Table 8: Power for the specific MRHC at α = 0.05
Disease Allele
Frequency
Model Type
Model 3 Model 4 Model 7 Model 8
0.1 0.981 0.856 0.978 0.946
0.3 0.943 0.962 0.916 0.937
0.5 0.933 0.954 0.946 0.952
Table 9: The best ten combinations in two regions with six markers
M o d e l 1 23 45 67 8 91 0
Model 5 2|5 12|5 23|5 123|5 245 234|5 123|45 12|56 123|56 12|456
Model 6 5 2 2|5 3|5 2|6 23 12 56 2|4 45
Model 7 2|5 12|45 13|456 123|45 2|45 23|45 123|56 12|456 123|45 12|56
Model 8 12|5 2|5 23|5 2|45 12|45 2|56 123|5 23|56 123|45 12|56
The possible number for the combination is 26-1 with 6 markers in 2 regions.BMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
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An MRHE is formed by two MRHCs from the two gam-
etes, but there may be 2R MRHCs for a given MRHE, some
of which may be the same. We construct an n × h matrix
with rows referring to the n individuals and columns
referring to the different MRHCs. Cell xef of this matrix
denotes the contribution of individual e to MRHC f, and
can be calculated according to the following equation,
Regression model with MRHC
Let y denote an n × 1 vector of measured phenotypes of a
trait, α denote an h × 1 vector of the effects for the MRHCs,
β denote the regression parameters for the intercept and
environmental factors,   be the contribution matrix
obtained above, and   denote the design matrix corre-
sponding to measured environmental factors. Then we
have the following generalized linear model (GLM):
Let Z = Xe|Xg and γ = (α|β). Then, the likelihood of trait yi
for subject i, given the vector Zi, can be expressed as a GLM
for exponential family data[36] according to
where a, b, and c are known functions, and ϕ is the disper-
sion parameter. To implement the score statistics for dif-
ferent types of traits, we need only assume a distribution
for the trait and to make the appropriate substitutions for
the expected value of the trait,  , the dispersion parame-
ter a(ϕ), the ratio b"(η)/a(ϕ) and the link function. (see
table 1 of [5]).
Score test for incorporating contribution of MRHC
We derive score statistics to test the null hypothesis of no
association between MRHC and trait, H0 : α = 0. Let ζ
denote the vector of nuisance parameters (β, μ, ϕ). The
likelihood function for (α, ζ) on the basis of the data
 according to Tzeng et al[6] is
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Table 10: All marker combinations with raw P values less than 0.01
Trait Type Number Marker Combination
BKa 15 3|67, 1|3|568, 1|3|7, 3|58, 2|3|58, 3|568, 3|57, 1|3|5, 1|3|57, 3|567, 1|3|56, 2|3|68, 1|3|78, 2|3|78, 3|578
Tendb 34 4|68, 4|56, 578, 568, 4|568, 1|4|58, 1|4|68, 4, 3|56, 1|2|57, 4|567, 3|58, 3|4|5, 1|57, 3|4|58, 3|568, 4|67, 5|67, 4|78, 58, 
5678 4|678, 4|58, 4|57, 3|4|7, 3|4|6, 3|578, 1|3|4|5, 1|4|5, 1|3|678, 3|4|578, 1|3|4|8, 1|3|56,1|3|5
DLc 4 1|3|678, 3|4|578, 567, 58
MCd 10 1|3|4|5, 3|4|678, 1|3|57, 1|568, 1|4|567, 1|4|57, 1|4|578, 1|56. 1|3|56, 1|3|67
IMFe 4 1|3|4|5, 1|4|56, 4, 568
pH1f 32 1|3|4|5, 1|3|5, 1|3|56, 1|3|57, 1|3|6, 1|3|67, 1|3|7, 1|4|567, 1|4|57, 1|4|578, 1|4|58, 1|4|6, 1|56, 1|578, 3|4|56, 3|4|6, 
3|4|678,3|4|7, 3|4|8, 3|56, 3|57, 3|568, 3|57, 3|58, 3|6, 3|67, 3|678, 3|7, 3|78, 4|56, 4|58, 4|6
pH24h 5 1|4|8, 3|4|8, 4|6, 58, 8
Proteini 8 1|3|6, 5, 1|5, 12|3, 1|4|8, 3|58, 1|3|8, 12|3|4|5
a back fat thickness, b tenderness, c drip loss, d meat color, e intramuscular fat content, f PH after 1 hour's slaughter, hPH after 24 hours' slaughter, i 
the content of protein. The eight markers (A1, A2, H1, M1, C1, C2, C3, C4) as 1 2 3 4 5 6 7 8, and same as follows.
Table 11: The specific MRHC of 4 regions of haplotype interaction
Trait Type The specfic haplotype configurations in 4 genes
BK AG|A|A|AGGA, AG|A|G|GGGA, AG|A|G|AGGA, AG|G|G|AGAA, AG|G|G|AGAA
Tend AG|A|G|AGGA, AG|A|G|AGGA, AG|A|G|AGGA, GG|A|A|AAAAa, GG|G|A|AAAAa
DL AG|A|G|AGAA, AG|A|G|AGGA, AG|G|G|AGAA, GG|G|A|AAAAa, AA|A|A|AAAAa
MC AG|A|A|AGGA, AG|A|G|AAGA, AG|A|G|AGAA, AG|A|G|AGGA, AG|G|G|AGAAa
IMF AG|A|G|AGAA, AG|A|G|AGGA, AA|G|G|AAAGa, AA|G|A|AAAGa, AG|G|G|AAGGa
pH1 AG|A|G|AGAA, AG|A|G|AGGA, AG|G|G|AGAA, AG|G|G|AAAAa, AG|A|A|AAGA
pH24 AG|A|G|AGAA, AG|A|G|AGGA, AG|G|G|AGAA, AG|A|A|AGGAa, AG|A|A|AAGAa
Protein AG|A|G|AGAA, AG|A|G|AGGA, AG|A|A|AGGA, AG|A|A|AGGAa, AA|A|A|AAGAa
a denote the statistics zk is very low.BMC Genetics 2009, 10:56 http://www.biomedcentral.com/1471-2156/10/56
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Where  P(xg,  i) is the contribution of individual i  to
MRHCs.
The score function for α is the partial derivative of the like-
lihood equation (5), with respect to α. The resulting score
statistic, denoted by Sα, is the score function evaluated at
the restricted maximum-likelihood estimate under the
null hypothesis. Sα is the statistic that we use to test MRHC
effect; in appendix A, we show the following result:
where   and   are the restricted maximum-likelihood
estimated under the null hypothesis, and E(Xg, i|Gi) is the
contribution of individual i to MRHC under the observed
multi-region genotypes, G.
To test the association between MRHC and trait that
adjusts for other covariates, we need to compute the vari-
ance of Sα under the null hypothesis H0: α = 0. Under H0,
Sα  is asymptotically distributed as multivariate nor-
mal[36]. We consider the generalized score test, which
would ensure the asymptotic null χ2 distribution even
under model misspecification[5]. Define θ = (α, ζ) and let
Vα  denote the variance of Sα, the equation can be
expressed according to Louis[37] and Tzeng et al[6] as:
where,
In appendix B, we show the above result.
With the above results, we can compute a global score sta-
tistic according to
The score statistic is distributed asymptotically as χ2 with
degrees of freedom equal to the rank of Vα.
Schaid et al[5] proved that the score function for α and the
score function for haplotype probabilities are independ-
ent under the null hypothesis, so that the covariance
between the two score functions is zero. Since the contri-
bution to each MRHC is estimated from the haplotype fre-
quency that is used to calculate the score statistic Sα, the
variance of the score statistic is not penalized by the use of
estimated haplotype frequencies.
In this framework, we can readily compute score statistics
for each MRHC according to[5]:
where zk follows χ2(1) under the null hypothesis H0: α = 0.
The P value   is assessed via simulation. In each repli-
cate of this simulation, a sample is constructed in which
the sample trait and environmental covariate of each indi-
vidual are randomly permuted at the same time, and the
score test statistic is computed again. Let   denote the
value of the test statistic obtained for the ith replicate.
Then   is the fraction of permutation replicates result-
ing in a test statistic greater than or equal to the test statis-
tic of the real data, i.e.,  , with t
denoting the number of permutation replicates and
| | denoting the
number of elements of  .
Testing more than one hypothesis
If we select m markers in several genes, there would be 2m-
1 marker combinations. To test 2m-1 combinations with
associated raw P values, and declare the global P value the
significance level for our analysis would lead to another
multiple-testing problem. In order to avoid nested simu-
lation, we use the method which Becker and Knapp[2]
adapted from Ge et al[13]. The basic idea is that, to test B
= 2m-1 marker combinations, global P is estimated by the
proportion of permutation samples with min BPt smaller
than that in the observed data, where t is the simulation
time. For each marker combination B ∈ B and for each
permutation replicate i = 1,..., t, the raw P value of the ith
permutation replicate is calculated as
For  i  > 0,   is the minimum of the
uncorrected P values over all MRHC in the ith permuta-
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tion replicate. So the P value for the global hypothesis H0
is calculated as:
This permutation method is explained in more detail
in[2].
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Appendix A
Let Sα (Y, G, Xe, α, ζ) denote the score function of the data
(Y, G, Xe) for α. As set forth by[37], Sα (Y, G, Xe, α, ζ) is the
expectation of the complete-data score function given the
observed data--that is,
Appendix B
For the expected Fisher information function of the
observed data (Y, G, Xe), I is
where
The hybrid estimate of I  is obtained by replacing the
nonzero entries of I with the observed Fisher information
(denoted by i):
Hence, equation (7) can be simplified as
Recall that
and that[37] proposed
so that
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